The Ministry of Health of the Russian Federation improves patent protection law

18 September 2018

GMP News

The Ministry of Health of Russia has published a notification on the development of amendments to Federal Law No. 61 of 12.04.2010 “On circulation of medicinal products”, designed to synchronize it with regulatory acts of the Eurasian Economic Union.

The procedure for registration of the medicinal product will be corrected.

According to information published on the state web portal for draft normative and legal acts, pursuant to Article 7 of the Agreement on Uniform Principles and Rules for the circulation of medicinal products within the Eurasian Economic Union, the Rules for Registration and Expert Examination of Medicinal Products for Human Use have been approved. The Rules require submission of information on the existence of intellectual rights to a medicinal product protected by patents in force in the territory of a member state of the Eurasian Economic Union, when registering medicinal products.

Therefore, the Ministry of Health of the Russian Federation proposes amendments to the Federal Law “On circulation of medicinal products”, requiring that for the state registration of medicinal products for human use, the applicant should submit information on the existing protection of intellectual property rights for the claimed medicinal product, and also confirming that the registration of the medicinal product does not violate the rights of third parties to intellectual property.


Previous publication Next publication

Media Center

  • 19 October 2018

    FDA Publishes Guidance on the Rare Disease Treatments

    FDA published draft guidance on October 15, 2018 to assist sponsors developing treatments for rare diseases plan for pre-investigational new drug application (pre-IND) meetings with FDA. In the guidance, the agency describes topics that should be considered in early drug development and pre-IND meetings.

  • 18 October 2018

    Russia emerges as frontrunner in global fight against tuberculosis

    Russia has turned out to be the world’s most successful tuberculosis fighter, Russian Health Minister Veronika Skvortsova stated  during the interview with the Rossiya-24 channel. "We are the global leader according to the pace in solving this issue," she noted, adding, "all countries acknowledge Russia’s foremost role here."

  • 17 October 2018

    Scientists developed new tool for open exchange of biomaterials

    A new easy-to-use legal tool that enables open exchange of biological materials was launched. The OpenMTA is a Material Transfer Agreement (MTA) designed to support openness, sharing and innovation in global biotechnology. Material Transfer Agreements (MTAs) provide the legal frameworks within which research organisations define terms and conditions for sharing their materials – everything from DNA molecules to plant seeds to patient samples.

  • 16 October 2018

    The First FDA-approved Digital Pill — What It Means for Pharma

    Last year, the U.S. Food and Drug Administration (FDA) approved what is perhaps the boldest use of digital technology in healthcare: a pill that is integrated with an ingestible sensor that captures information about whether the patient has complied with her medication regimen. A patient ingests the pill and it sends the data to a patch worn on her torso, which adds various physiologic measures. From there the information is wirelessly sent to a mobile phone app, allowing both the patient and her physician to track how the patient is using and responding to her medication.

Read more